Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB
Mandate

Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB

January 13, 2021 Employment and Benefits Corporate Crime & Compliance Real Estate and Construction M&A General Corporate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Göteborg Mark och Betong Entreprenad AB (“GMB”).

GMB is based in Gothenburg and provides construction and contracting services related to infrastructure, foundation and fine planning work as well as both cast-in-place and prefabricated concrete. GMB has a total approximate revenue of SEK 220 million and around 30 employees.

Vinge’s team consisted primarily of partner Christina Kokko and associates Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Frida Ställborn (Real Property & Environment), Tove Lövgren Frisk (Compliance) and Carl Bruneheim (VDR-specialist).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025